Anders Gustavsson, partner vid Quantify, och professor Bengt Winblad vid Karolinska institutet har skrivit rapporten Alzheimers sjukdom – en utmaning för Sverige. Läs den här: Alzheimers sjukdom – en utmaning för Sverige 20210701. Rapporten syftar till att ge en […]
The unavailability of medicines can be both problematic and lead to severe consequences for patients in need of therapy. However, in many cases other treatment alternatives can be provided. Quantify, in collaboration […]
A new systematic literature review on patient quality of life in Alzheimer’s disease is now published. The study was co-authored by Anders Gustavsson and is part of the Innovative Medicines Initiative project […]
Quantify’s Ingrid, Mathias and Kirk are co-authors on an population-based Swedish RWE study of incidence of psoriaticarthritis in adults with skin psoriasis published in Acta D-V, and presented at AAD2020. The results showed that if 10,000 patients with skin psoriasis […]
Anders Gustavsson is co-author of a recently published Alzheimer study presenting a cross-walk between the generic health utility measure EQ5D and the disease specific health-related quality of life measure QoL-AD.
A free full text version is available here.
The paper “Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish Study” by Quantify’s Kirk Geale and coauthors has been published in JAMA Dermatology. […]